Lusaris is a biotech company specializing in serotonergic neuroplastogens therapeutics. It develops treatment programs for patients suffering from neuropsychiatric and neurological disorders, including depression, migraine, cluster headaches, etc. The programs are based on the application of psychedelic agents such as LSD, psilocybin, and 5-MeO-DMT.